Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A S Belldegrun

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
The Cancer Journal From Scientific American|June 5, 1998
Interferon and kidney cancer: a promise unfulfilled?J Naitoh, A S Belldegrun
British Journal of Urology|March 1, 1997
Development of gene therapy for prostate cancer using a novel promoter of prostate-specific antigenJ Dannull, A S Belldegrun
The Journal of Urology|July 4, 2001
Towards kidney cancer crystal ball. Better prognostication of patients with renal cell carcinomaS J Freedland, A S Belldegrun
Current Urology Reports|June 27, 2002
Phase I clinical trial of interleukin 2 (IL-2) gene therapy for prostate cancerA J Pantuck, A S Belldegrun
Mayo Clinic Proceedings|June 8, 2001
The utility of PSA doubling time to monitor prostate cancer recurrenceJ A Wieder, A S Belldegrun
Reviews in Urology|September 21, 2006
Innovative Strategies Proposed at the Western AUA Meeting: Highlights From the Annual Meeting of the Western Section of the American Urological Association September 26-30, 1999, Monterey, CaliforniaA J Pantuck, A S Belldegrun
BJU International|December 18, 2003
Third-generation cryosurgery for primary and recurrent prostate cancerK-R Han, A S Belldegrun
Reviews in Urology|September 21, 2006
Molecular markers for renal cell carcinomaA J Pantuck, A Zisman, A S Belldegrun
World Journal of Urology|June 15, 2000
Gene therapy for prostate cancer at the University of California, Los Angeles: preliminary results and future directionsA J Pantuck, A Zisman, A S Belldegrun
The Journal of Urology|October 5, 2001
The changing natural history of renal cell carcinomaA J Pantuck, A Zisman, A S Belldegrun
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
The Cancer Journal From Scientific American|June 5, 1998
Interferon and kidney cancer: a promise unfulfilled?J Naitoh, A S Belldegrun
British Journal of Urology|March 1, 1997
Development of gene therapy for prostate cancer using a novel promoter of prostate-specific antigenJ Dannull, A S Belldegrun
The Journal of Urology|July 4, 2001
Towards kidney cancer crystal ball. Better prognostication of patients with renal cell carcinomaS J Freedland, A S Belldegrun
Current Urology Reports|June 27, 2002
Phase I clinical trial of interleukin 2 (IL-2) gene therapy for prostate cancerA J Pantuck, A S Belldegrun
Mayo Clinic Proceedings|June 8, 2001
The utility of PSA doubling time to monitor prostate cancer recurrenceJ A Wieder, A S Belldegrun
Reviews in Urology|September 21, 2006
Innovative Strategies Proposed at the Western AUA Meeting: Highlights From the Annual Meeting of the Western Section of the American Urological Association September 26-30, 1999, Monterey, CaliforniaA J Pantuck, A S Belldegrun
BJU International|December 18, 2003
Third-generation cryosurgery for primary and recurrent prostate cancerK-R Han, A S Belldegrun
Reviews in Urology|September 21, 2006
Molecular markers for renal cell carcinomaA J Pantuck, A Zisman, A S Belldegrun
World Journal of Urology|June 15, 2000
Gene therapy for prostate cancer at the University of California, Los Angeles: preliminary results and future directionsA J Pantuck, A Zisman, A S Belldegrun
The Journal of Urology|October 5, 2001
The changing natural history of renal cell carcinomaA J Pantuck, A Zisman, A S Belldegrun
Pageof 5